Brown-Forman-A
BF.A
26.46
-0.44
-1.64%
Brown-Forman-A
US · BF.A
#1304 by market cap
Listed 1970
26.46
-0.44
-1.64%
Live - 5344 symbols - heartbeat 72s ago
· 2026-10-08 02:06
After-hours
26.46
0.00%
Overnight
27.28
+3.10%
- Market cap
- 12.14B
- P/E (TTM)i
- 17.07
- P/Bi
- 3.06
- EPSi
- 1.53
- Div yieldi
- 3.48%
- 52W posi
- 48%
Reader sentiment
Are you bullish or bearish on BF.A?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.17, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -1.18% YoY
Margins
- Gross margin
- 60.54%
- Operating margin
- 29.33%
- Net margin
- 18.20%
Key ratios & quality
- Enterprise valuei
- 14.34B
- Altman Z-Scorei
- 4.17
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 3.32B | 3.36B | 3.46B | 3.93B | 4.23B | 4.18B | 3.98B | 3.93B |
| Gross profit | 2.17B | 2.13B | 2.09B | 2.39B | 2.49B | 2.53B | 2.34B | 2.38B |
| Selling & admin expenses | 1.04B | 1.03B | 1.07B | 1.13B | 1.25B | 1.36B | 1.23B | 1.27B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.14B | 1.09B | 1.04B | 1.20B | 1.13B | 1.15B | 1.21B | 1.15B |
| Pretax profit | 1.04B | 1.01B | 1.08B | 1.11B | 1.02B | 1.30B | 1.08B | 885.00M |
| Tax | 207.00M | 182.00M | 178.00M | 276.00M | 234.00M | 274.00M | 212.00M | 170.00M |
| Net profit | 835.00M | 827.00M | 903.00M | 838.00M | 783.00M | 1.02B | 869.00M | 715.00M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.73 | 1.72 | 1.88 | 1.74 | 1.63 | 2.14 | 1.84 | 1.53 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 894.00M | 924.00M | 1.04B | 1.06B | 912.00M | 911.00M |
| Gross profit | 513.00M | 552.00M | 615.00M | 640.00M | 571.00M | 549.00M |
| Selling & admin expenses | 300.00M | 297.00M | 313.00M | 304.00M | 355.00M | 299.00M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 279.00M | 272.00M | 309.00M | 343.00M | 228.00M | 252.00M |
| Pretax profit | 183.00M | 220.00M | 279.00M | 315.00M | 71.00M | 229.00M |
| Tax | 37.00M | 50.00M | 55.00M | 48.00M | 17.00M | 53.00M |
| Net profit | 146.00M | 170.00M | 224.00M | 267.00M | 54.00M | 176.00M |
| Basic EPS | 0 | 0 | 0 | 1 | 0 | 0 |
| Diluted EPS | 0.31 | 0.36 | 0.47 | 0.58 | 0.12 | 0.38 |
Balance sheet
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 2.72B | 3.27B | 3.92B | 3.78B | 3.80B | 4.04B | 4.20B | 3.99B |
| Cash & ST investments | 307.00M | 675.00M | 1.15B | 868.00M | 374.00M | 446.00M | 444.00M | 308.00M |
| Inventory | 1.52B | 1.69B | 1.75B | 1.82B | 2.28B | 2.56B | 2.51B | 2.54B |
| Total assets | 5.14B | 5.77B | 6.52B | 6.37B | 7.78B | 8.17B | 8.09B | 7.89B |
| Total current liabilities | 703.00M | 880.00M | 918.00M | 1.03B | 1.08B | 1.56B | 1.08B | 1.23B |
| Short-term debt | 166.00M | 333.00M | 205.00M | 250.00M | 235.00M | 728.00M | 312.00M | 419.00M |
| Long-term debt | 2.29B | 2.27B | 2.35B | 2.02B | 2.68B | 2.37B | 2.42B | 2.08B |
| Total liabilities | 3,492,000,000.00 | 3,791,000,000.00 | 3,866,000,000.00 | 3,636,000,000.00 | 4,509,000,000.00 | 4,649,000,000.00 | 4,093,000,000.00 | 3,874,000,000.00 |
| Total equity | 1.65B | 1.98B | 2.66B | 2.74B | 3.27B | 3.52B | 3.99B | 4.02B |
| Retained earnings | 2.24B | 2.71B | 3.24B | 3.24B | 3.64B | 4.26B | 4.71B | 5.00B |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 4.20B | 4.18B | 4.21B | 4.23B | 3.99B | 3.96B |
| Cash & ST investments | 444.00M | 471.00M | 319.00M | 383.00M | 308.00M | 301.00M |
| Inventory | 2.51B | 2.59B | 2.56B | 2.56B | 2.54B | 2.57B |
| Total assets | 8.09B | 8.17B | 8.22B | 8.30B | 7.89B | 7.83B |
| Total current liabilities | 1.08B | 1.50B | 1.42B | 1.53B | 1.23B | 1.21B |
| Short-term debt | 312.00M | 626.00M | 575.00M | 656.00M | 419.00M | 359.00M |
| Long-term debt | 2.42B | 2.08B | 2.07B | 2.09B | 2.08B | 2.08B |
| Total liabilities | 4,093,000,000.00 | 4,183,000,000.00 | 4,087,000,000.00 | 4,220,000,000.00 | 3,874,000,000.00 | 3,856,000,000.00 |
| Total equity | 3.99B | 3.99B | 4.13B | 4.08B | 4.02B | 3.97B |
| Retained earnings | 4.71B | 4.67B | 4.89B | 5.05B | 5.00B | 4.96B |
Cash flow
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 800.00M | 724.00M | 817.00M | 936.00M | 640.00M | 647.00M | 598.00M | 1.00B |
| Depreciation & amortization | 72.00M | 74.00M | 77.00M | 79.00M | 80.00M | 87.00M | 87.00M | 92.00M |
| Free cash flow | 679.00M | 611.00M | 755.00M | 798.00M | 457.00M | 419.00M | 431.00M | 893.00M |
| Dividends paid | -310.00M | -325.00M | -338.00M | -831.00M | -378.00M | -404.00M | -420.00M | -427.00M |
| Stock buybacks / issuance | -207.00M | -1.00M | -- | 0 | 0 | -400.00M | 0 | -400.00M |
| Ending cash balance | 307.00M | 675.00M | 1.15B | 868.00M | 374.00M | 446.00M | 444.00M | 308.00M |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 152.00M | 160.00M | 132.00M | 417.00M | 291.00M | 173.00M |
| Depreciation & amortization | 21.00M | 22.00M | 22.00M | 24.00M | 24.00M | 23.00M |
| Free cash flow | 102.00M | 129.00M | 107.00M | 392.00M | 265.00M | 161.00M |
| Dividends paid | -107.00M | -107.00M | -107.00M | -107.00M | -106.00M | -106.00M |
| Stock buybacks / issuance | 0 | -- | -- | -301.00M | 0 | -- |
| Ending cash balance | 444.00M | 471.00M | 319.00M | 383.00M | 308.00M | 301.00M |
Returns & efficiency
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 56.36 | 45.67 | 39.00 | 31.08 | 26.08 | 30.18 | 23.14 | 17.85 |
| ROA %i | 16.51 | 15.17 | 14.70 | 13.00 | 11.07 | 12.85 | 10.69 | 8.95 |
| ROIC %i | 22.59 | 20.55 | 19.79 | 17.53 | 15.11 | 17.39 | 14.29 | 11.88 |
| 5-year avg ROE %i | 50.34 | 52.52 | 48.01 | 45.10 | 39.64 | 34.40 | 29.90 | 25.67 |
| EBIT margin %i | 34.00 | 32.44 | 33.57 | 30.41 | 26.18 | 34.11 | 30.26 | 25.15 |
| FCF / sales %i | 20.43 | 17.99 | 21.73 | 20.29 | 10.81 | 10.03 | 10.84 | 22.73 |
| Current ratioi | 3.87 | 3.71 | 4.27 | 3.65 | 3.51 | 2.59 | 3.88 | 3.24 |
| Quick ratioi | 1.30 | 1.41 | 2.07 | 1.63 | 1.13 | 0.78 | 1.18 | 0.93 |
| Debt / assetsi | 48.51 | 45.13 | 39.24 | 35.60 | 37.46 | 37.96 | 33.80 | 31.70 |
| LT debt / equityi | 141.29 | 114.89 | 88.63 | 73.77 | 81.95 | 67.44 | 60.63 | 51.82 |
| Interest coveragei | 12.84 | 13.30 | 14.35 | 14.59 | 12.30 | 11.22 | 9.86 | 9.59 |
| Revenue CAGR (3Y) %i | 2.47 | 3.95 | 2.14 | 5.77 | 7.93 | 6.48 | 0.35 | -2.42 |
| Net income CAGR (3Y) %i | -7.85 | 7.32 | 7.99 | 0.12 | -1.81 | 4.28 | 1.22 | -2.98 |
| FCF CAGR (3Y) %i | 17.93 | 4.14 | 12.87 | 5.53 | -9.23 | -17.82 | -18.56 | 25.02 |
| Line item | 2025-04 | 2025-07 | 2025-10 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 23.14 | 22.65 | 20.67 | 20.42 | 17.85 | 18.12 |
| ROA %i | 10.69 | 10.31 | 9.79 | 9.86 | 8.95 | 9.01 |
| ROIC %i | 14.29 | 13.86 | 12.91 | 13.00 | 11.88 | 12.12 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 30.26 | 29.46 | 28.88 | 28.16 | 25.15 | 25.47 |
| FCF / sales %i | 10.84 | 14.79 | 15.69 | 18.67 | 22.73 | 23.63 |
| Current ratioi | 3.88 | 2.79 | 2.97 | 2.77 | 3.24 | 3.26 |
| Quick ratioi | 1.18 | 0.88 | 0.96 | 0.89 | 0.93 | 0.93 |
| Debt / assetsi | 33.80 | 33.06 | 32.20 | 33.06 | 31.70 | 31.21 |
| LT debt / equityi | 60.63 | 52.03 | 50.12 | 51.18 | 51.82 | 52.48 |
| Interest coveragei | 9.86 | 10.11 | 10.30 | 10.59 | 9.59 | 9.68 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Whiskey is the largest reported line at 72.23% of revenue, across 5 reported segments.
- The next-largest line, Ready-to-Drink, is a distant second at 16.90% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Whiskey72.23%
Ready-to-Drink16.90%
Tequila5.93%
Rest of portfolio4.28%
Non-branded and bulk0.66%
Quote time 2026-10-08 02:06:37 · For reference only, not investment advice and not tailored to your situation.